US Stock MarketDetailed Quotes

NGNE Neurogene

Watchlist

25.430
-0.370-1.43%

Close Nov 29 13:00 ET

25.690
+0.260+1.02%

Post 17:01 ET

377.76MMarket Cap-8979P/E (TTM)

Neurogene Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-34.54%-15.56M

-70.40%-15.89M

-59.72%-21.65M

2.65%-51.42M

-16.97M

-11.57M

-9.33M

-13.56M

-13.84%-52.82M

-46.4M

Net income from continuing operations

-38.69%-20.22M

-55.92%-18.49M

-37.98%-16.92M

34.20%-36.32M

--2.38M

---14.58M

---11.86M

---12.26M

-9.25%-55.19M

---50.52M

Depreciation and amortization

-2.54%807K

-0.73%817K

0.86%825K

3.03%3.3M

--828K

--823K

--818K

237.91%3.2M

--947K

Other non cash items

-399.40%-503K

310.37%673K

215.63%505K

-2,680.92%-15.69M

---16.18M

--168K

--164K

--160K

-10.46%608K

--679K

Change In working capital

57.53%2.56M

-175.65%-879K

-163.32%-6.75M

-49.28%-4.02M

---4.25M

--1.63M

--1.16M

---2.56M

-268.97%-2.7M

--1.6M

-Change in prepaid assets

353.81%599K

-535.62%-636K

-81.67%-1.42M

-54.47%326K

--1.2M

---236K

--146K

---780K

136.14%716K

---1.98M

-Change in payables and accrued expense

28.53%2.61M

-62.81%440K

-193.02%-4.74M

-3.78%-2.91M

---4.5M

--2.03M

--1.18M

---1.62M

-165.97%-2.8M

--4.25M

-Change in other current assets

--5K

---51K

--21K

---764K

--0

----

-Change in other current liabilities

-284.71%-654K

-278.44%-632K

-271.34%-609K

-11.15%-678K

---177K

---170K

---167K

---164K

8.96%-610K

---670K

Cash from discontinued investing activities

Operating cash flow

-34.54%-15.56M

-70.40%-15.89M

-59.72%-21.65M

2.65%-51.42M

---16.97M

---11.57M

---9.33M

---13.56M

-13.84%-52.82M

---46.4M

Investing cash flow

Cash flow from continuing investing activities

-35,224.39%-28.97M

-28,697.56%-23.61M

103,324.14%29.94M

1,249.64%25.64M

25.83M

-82K

-29K

87.86%-2.23M

-18.37M

Net PPE purchase and sale

-103.66%-167K

-460.98%-460K

-124.14%-65K

85.61%-321K

---128K

---82K

---29K

87.86%-2.23M

---18.37M

Net investment purchase and sale

---28.8M

---23.15M

--30M

--5M

--0

----

Net other investing changes

----

--20.96M

----

Cash from discontinued investing activities

Investing cash flow

-35,224.39%-28.97M

-28,697.56%-23.61M

103,324.14%29.94M

1,249.64%25.64M

--25.83M

---82K

---29K

87.86%-2.23M

---18.37M

Financing cash flow

Cash flow from continuing financing activities

107.14%131K

563.95%399K

-6,197.20%-6.52M

39.01%92.48M

94.3M

-1.84M

-86K

107K

30.29%66.53M

51.06M

Net issuance payments of debt

-20.00%-12K

-166.67%-16K

-120.00%-11K

-2,800.00%-29K

---8K

---10K

---6K

---5K

---1K

--0

Net common stock issuance

----

--92.34M

----

--0

----

Net preferred stock issuance

----

--0

----

30.89%66.46M

--50.78M

Proceeds from stock option exercised by employees

308.57%143K

1,975.00%415K

461.61%629K

130.14%168K

--1K

--35K

--20K

--112K

-74.56%73K

--287K

Net other financing activities

--0

---7.14M

----

---1.86M

----

Cash from discontinued financing activities

Financing cash flow

107.14%131K

563.95%399K

-6,197.20%-6.52M

39.01%92.48M

--94.3M

---1.84M

---86K

--107K

30.29%66.53M

--51.06M

Net cash flow

Beginning cash position

88.61%111.37M

119.54%150.48M

81.32%148.72M

16.27%82.02M

--45.56M

--59.05M

--68.54M

--82.02M

-16.27%70.54M

--84.25M

Current changes in cash

-229.22%-44.4M

-311.88%-39.11M

113.07%1.76M

481.14%66.7M

--103.16M

---13.49M

---9.5M

---13.48M

183.74%11.48M

---13.71M

End cash Position

46.99%66.97M

88.61%111.37M

119.54%150.48M

81.32%148.72M

--148.72M

--45.56M

--59.05M

--68.54M

16.27%82.02M

--70.54M

Free cash flow

-35.03%-15.73M

-73.80%-16.35M

-59.86%-21.72M

6.01%-51.74M

---17.1M

---11.65M

---9.41M

---13.58M

15.00%-55.05M

---64.77M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-34.54%-15.56M	-70.40%-15.89M	-59.72%-21.65M	2.65%-51.42M	-16.97M	-11.57M	-9.33M	-13.56M	-13.84%-52.82M	-46.4M
Net income from continuing operations	-38.69%-20.22M	-55.92%-18.49M	-37.98%-16.92M	34.20%-36.32M	--2.38M	---14.58M	---11.86M	---12.26M	-9.25%-55.19M	---50.52M
Depreciation and amortization	-2.54%807K	-0.73%817K	0.86%825K	3.03%3.3M	--828K	--828K	--823K	--818K	237.91%3.2M	--947K
Other non cash items	-399.40%-503K	310.37%673K	215.63%505K	-2,680.92%-15.69M	---16.18M	--168K	--164K	--160K	-10.46%608K	--679K
Change In working capital	57.53%2.56M	-175.65%-879K	-163.32%-6.75M	-49.28%-4.02M	---4.25M	--1.63M	--1.16M	---2.56M	-268.97%-2.7M	--1.6M
-Change in prepaid assets	353.81%599K	-535.62%-636K	-81.67%-1.42M	-54.47%326K	--1.2M	---236K	--146K	---780K	136.14%716K	---1.98M
-Change in payables and accrued expense	28.53%2.61M	-62.81%440K	-193.02%-4.74M	-3.78%-2.91M	---4.5M	--2.03M	--1.18M	---1.62M	-165.97%-2.8M	--4.25M
-Change in other current assets	--5K	---51K	--21K	---764K	---764K	--0	--0	--0	--0	----
-Change in other current liabilities	-284.71%-654K	-278.44%-632K	-271.34%-609K	-11.15%-678K	---177K	---170K	---167K	---164K	8.96%-610K	---670K
Cash from discontinued investing activities
Operating cash flow	-34.54%-15.56M	-70.40%-15.89M	-59.72%-21.65M	2.65%-51.42M	---16.97M	---11.57M	---9.33M	---13.56M	-13.84%-52.82M	---46.4M
Investing cash flow
Cash flow from continuing investing activities	-35,224.39%-28.97M	-28,697.56%-23.61M	103,324.14%29.94M	1,249.64%25.64M	25.83M	-82K	-82K	-29K	87.86%-2.23M	-18.37M
Net PPE purchase and sale	-103.66%-167K	-460.98%-460K	-124.14%-65K	85.61%-321K	---128K	---82K	---82K	---29K	87.86%-2.23M	---18.37M
Net investment purchase and sale	---28.8M	---23.15M	--30M	--5M	--5M	--0	--0	--0	--0	----
Net other investing changes	----	----	----	--20.96M	----	----	----	----	----	----
Cash from discontinued investing activities
Investing cash flow	-35,224.39%-28.97M	-28,697.56%-23.61M	103,324.14%29.94M	1,249.64%25.64M	--25.83M	---82K	---82K	---29K	87.86%-2.23M	---18.37M
Financing cash flow
Cash flow from continuing financing activities	107.14%131K	563.95%399K	-6,197.20%-6.52M	39.01%92.48M	94.3M	-1.84M	-86K	107K	30.29%66.53M	51.06M
Net issuance payments of debt	-20.00%-12K	-166.67%-16K	-120.00%-11K	-2,800.00%-29K	---8K	---10K	---6K	---5K	---1K	--0
Net common stock issuance	----	----	----	--92.34M	----	----	----	----	--0	----
Net preferred stock issuance	----	----	----	--0	----	----	----	----	30.89%66.46M	--50.78M
Proceeds from stock option exercised by employees	308.57%143K	1,975.00%415K	461.61%629K	130.14%168K	--1K	--35K	--20K	--112K	-74.56%73K	--287K
Net other financing activities	--0	--0	---7.14M	----	----	---1.86M	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	107.14%131K	563.95%399K	-6,197.20%-6.52M	39.01%92.48M	--94.3M	---1.84M	---86K	--107K	30.29%66.53M	--51.06M
Net cash flow
Beginning cash position	88.61%111.37M	119.54%150.48M	81.32%148.72M	16.27%82.02M	--45.56M	--59.05M	--68.54M	--82.02M	-16.27%70.54M	--84.25M
Current changes in cash	-229.22%-44.4M	-311.88%-39.11M	113.07%1.76M	481.14%66.7M	--103.16M	---13.49M	---9.5M	---13.48M	183.74%11.48M	---13.71M
End cash Position	46.99%66.97M	88.61%111.37M	119.54%150.48M	81.32%148.72M	--148.72M	--45.56M	--59.05M	--68.54M	16.27%82.02M	--70.54M
Free cash flow	-35.03%-15.73M	-73.80%-16.35M	-59.86%-21.72M	6.01%-51.74M	---17.1M	---11.65M	---9.41M	---13.58M	15.00%-55.05M	---64.77M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data